FDA Approved: SUMATRIPTAN — Supplemental Application (ONESOURCE SPECIALTY PHARMA LIMITED)

View source ↗

Summary

FDA approved a supplemental application for SUMATRIPTAN from ONESOURCE SPECIALTY PHARMA LIMITED, approving a modification to the existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)